Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Abstract Background Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI), formulated using c...

Full description

Bibliographic Details
Main Authors: Edward M. Kerwin, Gary T. Ferguson, Mindy Mo, Kiernan DeAngelis, Paul Dorinsky
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Respiratory Research
Subjects:
BGF MDI
Bone mineral density
Inhaled corticosteroid
Lens opacity
LOCS III
Metered dose inhaler
Online Access:http://link.springer.com/article/10.1186/s12931-019-1126-7

Internet

http://link.springer.com/article/10.1186/s12931-019-1126-7

Similar Items